203 related articles for article (PubMed ID: 26588862)
1. An integrated genomic analysis of Tudor domain-containing proteins identifies PHD finger protein 20-like 1 (PHF20L1) as a candidate oncogene in breast cancer.
Jiang Y; Liu L; Shan W; Yang ZQ
Mol Oncol; 2016 Feb; 10(2):292-302. PubMed ID: 26588862
[TBL] [Abstract][Full Text] [Related]
2. Methyllysine reader plant homeodomain (PHD) finger protein 20-like 1 (PHF20L1) antagonizes DNA (cytosine-5) methyltransferase 1 (DNMT1) proteasomal degradation.
Estève PO; Terragni J; Deepti K; Chin HG; Dai N; Espejo A; Corrêa IR; Bedford MT; Pradhan S
J Biol Chem; 2014 Mar; 289(12):8277-87. PubMed ID: 24492612
[TBL] [Abstract][Full Text] [Related]
3. Integrative genomic and transcriptomic analysis for pinpointing recurrent alterations of plant homeodomain genes and their clinical significance in breast cancer.
Yu H; Jiang Y; Liu L; Shan W; Chu X; Yang Z; Yang ZQ
Oncotarget; 2017 Feb; 8(8):13099-13115. PubMed ID: 28055972
[TBL] [Abstract][Full Text] [Related]
4. PHF20L1 as a H3K27me2 reader coordinates with transcriptional repressors to promote breast tumorigenesis.
Hou Y; Liu W; Yi X; Yang Y; Su D; Huang W; Yu H; Teng X; Yang Y; Feng W; Zhang T; Gao J; Zhang K; Qiu R; Wang Y
Sci Adv; 2020 Apr; 6(16):eaaz0356. PubMed ID: 32494608
[TBL] [Abstract][Full Text] [Related]
5. Methyl-lysine readers PHF20 and PHF20L1 define two distinct gene expression-regulating NSL complexes.
Van HT; Harkins PR; Patel A; Jain AK; Lu Y; Bedford MT; Santos MA
J Biol Chem; 2022 Mar; 298(3):101588. PubMed ID: 35033534
[TBL] [Abstract][Full Text] [Related]
6. An insight into the promoter methylation of PHF20L1 and the gene association with metastasis in breast cancer.
Sierra-Ramirez JA; Seseña-Mendez E; Godinez-Victoria M; Hernandez-Caballero ME
Adv Clin Exp Med; 2021 May; 30(5):507-515. PubMed ID: 33847474
[TBL] [Abstract][Full Text] [Related]
7. Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer.
Liu H; Liu L; Holowatyj A; Jiang Y; Yang ZQ
Mol Carcinog; 2016 May; 55(5):977-90. PubMed ID: 26207617
[TBL] [Abstract][Full Text] [Related]
8. Genotranscriptomic meta-analysis of the CHD family chromatin remodelers in human cancers - initial evidence of an oncogenic role for CHD7.
Chu X; Guo X; Jiang Y; Yu H; Liu L; Shan W; Yang ZQ
Mol Oncol; 2017 Oct; 11(10):1348-1360. PubMed ID: 28649742
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
[TBL] [Abstract][Full Text] [Related]
10. LSD1 demethylase and the methyl-binding protein PHF20L1 prevent SET7 methyltransferase-dependent proteolysis of the stem-cell protein SOX2.
Zhang C; Hoang N; Leng F; Saxena L; Lee L; Alejo S; Qi D; Khal A; Sun H; Lu F; Zhang H
J Biol Chem; 2018 Mar; 293(10):3663-3674. PubMed ID: 29358331
[TBL] [Abstract][Full Text] [Related]
11. Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins.
Tryndyak VP; Kovalchuk O; Pogribny IP
Cancer Biol Ther; 2006 Jan; 5(1):65-70. PubMed ID: 16322686
[TBL] [Abstract][Full Text] [Related]
12. PHF20L1 antagonizes SOX2 proteolysis triggered by the MLL1/WDR5 complexes.
Wang Q; Yu M; Ma Y; Zhang X; Zhang H; Li S; Lan R; Lu F
Lab Invest; 2018 Dec; 98(12):1627-1641. PubMed ID: 30089852
[TBL] [Abstract][Full Text] [Related]
13. Transforming properties of 8p11-12 amplified genes in human breast cancer.
Yang ZQ; Liu G; Bollig-Fischer A; Giroux CN; Ethier SP
Cancer Res; 2010 Nov; 70(21):8487-97. PubMed ID: 20940404
[TBL] [Abstract][Full Text] [Related]
14. Genetic alterations of histone lysine methyltransferases and their significance in breast cancer.
Liu L; Kimball S; Liu H; Holowatyj A; Yang ZQ
Oncotarget; 2015 Feb; 6(4):2466-82. PubMed ID: 25537518
[TBL] [Abstract][Full Text] [Related]
15. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
[TBL] [Abstract][Full Text] [Related]
16. Conformational Selection in Ligand Recognition by the First Tudor Domain of PHF20L1.
Lv M; Gao J; Li M; Ma R; Li F; Liu Y; Liu M; Zhang J; Yao X; Wu J; Shi Y; Tang Y; Pan Y; Zhang Z; Ruan K
J Phys Chem Lett; 2020 Sep; 11(18):7932-7938. PubMed ID: 32885980
[TBL] [Abstract][Full Text] [Related]
17. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
Kn H; Bassal S; Tikellis C; El-Osta A
Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
[TBL] [Abstract][Full Text] [Related]
18. PHD finger protein 1 (PHF1) is a novel reader for histone H4R3 symmetric dimethylation and coordinates with PRMT5-WDR77/CRL4B complex to promote tumorigenesis.
Liu R; Gao J; Yang Y; Qiu R; Zheng Y; Huang W; Zeng Y; Hou Y; Wang S; Leng S; Feng D; Yu W; Sun G; Shi H; Teng X; Wang Y
Nucleic Acids Res; 2018 Jul; 46(13):6608-6626. PubMed ID: 29846670
[TBL] [Abstract][Full Text] [Related]
19. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase.
Fuks F; Hurd PJ; Deplus R; Kouzarides T
Nucleic Acids Res; 2003 May; 31(9):2305-12. PubMed ID: 12711675
[TBL] [Abstract][Full Text] [Related]
20. Tudor-domain protein PHF20L1 reads lysine methylated retinoblastoma tumour suppressor protein.
Carr SM; Munro S; Sagum CA; Fedorov O; Bedford MT; La Thangue NB
Cell Death Differ; 2017 Dec; 24(12):2139-2149. PubMed ID: 28841214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
